Green tea: cancer preventive beverage and/or drug

被引：164

作者：

Fujiki, H

Suganuma, M

Imai, K

Nakachi, K

机构：

[1] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Biochem, Tokushima 7708514, Japan

[2] Saitama Canc Ctr, Saitama 3620806, Japan

[3] Radiat Effects Res Fdn, Dept Epidemiol, Minato Ku, Hiroshima 7320815, Japan

来源：

CANCER LETTERS | 2002年 / 188卷 / 1-2期

基金：

日本学术振兴会;

关键词：

(-)-epigallocatechin gallate; polyphenols; lung cancer; chemoprevention; sulindac;

D O I：

10.1016/S0304-3835(02)00379-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Green tea and (-)-epigallocatechin gallate (EGCG) are now acknowledged cancer preventives in Japan and has made it possible for us to establish the concept of a cancer preventive beverage. For the general population, we recommend 10 cups of green tea daily supplemented with green tea tablets. For cancer patients following treatment, we here present new evidence that green tea and a cancer preventive drug, sulindac, have synergistic preventive effects. An approach to develop green tea capsules as a cancer preventive drug in the US is discussed, aiming at taking full advantage of this cancer preventive beverage. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：9 / 13

页数：5

共 18 条

[1] Two stages of cancer prevention with green tea [J].